Zobrazeno 1 - 10
of 11
pro vyhledávání: '"McClenahan SD"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
McClenahan SD; Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD USA., Krause PR; Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD USA. Electronic address: Philip.krause@fda.hhs.gov.
Publikováno v:
Vaccine [Vaccine] 2019 Feb 08; Vol. 37 (7), pp. 1001-1005. Date of Electronic Publication: 2019 Jan 11.
Autor:
McClenahan SD; Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA., Uhlenhaut C; Highly Pathogenic Viruses, Centre for Biological Threats and Special Pathogens, Robert Koch Institute, Berlin, Germany., Krause PR; Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA. Electronic address: Philip.krause@fda.hhs.gov.
Publikováno v:
Vaccine [Vaccine] 2014 Dec 12; Vol. 32 (52), pp. 7115-21. Date of Electronic Publication: 2014 Oct 27.
Autor:
McClenahan SD; Office of Vaccines Research and Review, Center for Biologics Evaluation and Research Food and Drug Administration., Krause PR; Office of Vaccines Research and Review, Center for Biologics Evaluation and Research Food and Drug Administration Philip.krause@fda.hhs.gov.
Publikováno v:
PDA journal of pharmaceutical science and technology [PDA J Pharm Sci Technol] 2014 Nov-Dec; Vol. 68 (6), pp. 552-5.
Autor:
McClenahan SD; Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, MD 20892, USA., Uhlenhaut C; Highly Pathogenic Viruses ZBS1, Centre for Biological Threats and Special Pathogens, Robert Koch Institute, Nordufer 20, 13353 Berlin, Germany., Krause PR; Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, MD 20892, USA. Electronic address: philip.krause@fda.hhs.gov.
Publikováno v:
Biologicals : journal of the International Association of Biological Standardization [Biologicals] 2014 Jan; Vol. 42 (1), pp. 34-41. Date of Electronic Publication: 2013 Dec 03.
Autor:
McClenahan SD; Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Maryland, USA., Scherba G, Borst L, Fredrickson RL, Krause PR, Uhlenhaut C
Publikováno v:
PloS one [PLoS One] 2013 Aug 12; Vol. 8 (8), pp. e68777. Date of Electronic Publication: 2013 Aug 12 (Print Publication: 2013).
Autor:
McClenahan SD; Office of Vaccines Research and Review, Center for Biologics Evaluation and Research, FDA/CBER, Bethesda, MD 20892-4555, United States., Krause PR, Uhlenhaut C
Publikováno v:
Vaccine [Vaccine] 2011 Jun 24; Vol. 29 (29-30), pp. 4745-53. Date of Electronic Publication: 2011 May 11.
Autor:
McClenahan SD; Department of Infectious Diseases and Pathology, College of Veterinary Medicine, University of Florida, Gainesville, FL 32610, USA., Bok K, Sosnovtsev SV, Neill JD, Burek KA, Beckmen KB, Smith AW, Green KY, Romero CH
Publikováno v:
Veterinary microbiology [Vet Microbiol] 2010 May 19; Vol. 142 (3-4), pp. 184-92. Date of Electronic Publication: 2009 Oct 20.
Autor:
McClenahan SD; Department of Infectious Diseases and Pathology, College of Veterinary Medicine, University of Florida, 2015 SW 16th Avenue, Gainesville, FL 32610, USA., Bok K, Neill JD, Smith AW, Rhodes CR, Sosnovtsev SV, Green KY, Romero CH
Publikováno v:
Journal of virological methods [J Virol Methods] 2009 Oct; Vol. 161 (1), pp. 12-8. Date of Electronic Publication: 2009 May 03.